Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 7 November 2014, 08:50 HKT/SGT
Share:
    

Source: INC Research, LLC
INC Research Announces Pricing of Initial Public Offering
Stock expected to begin trading Nov. 7 on The Nasdaq Global Market under ticker symbol "INCR"

Raleigh, N.C., Nov 7, 2014 - (ACN Newswire) - INC Research Holdings, Inc. (INC Research), a leading, global Phase I to IV contract research organization, today announced the pricing of its initial public offering of 8,108,108 shares of its Class A common stock at a price to the public of $18.50 per share. The shares of INC Research's Class A common stock are expected to begin trading on The Nasdaq Global Market under the ticker symbol "INCR" on Nov. 7, 2014.

Goldman, Sachs & Co. and Credit Suisse served as joint lead book-running managers for the offering. Baird, Wells Fargo Securities and William Blair served as co-managers for the offering.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on Nov. 6, 2014. The offering of these securities was made only by means of a prospectus, copies of which may be obtained from Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, phone: +1-866-471-2526, email: prospectus-ny@ny.email.gs.com; or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, phone: +1-800-221-1037, email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About INC Research

INC Research is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. We were ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries.

Contact:
Investors: Ronnie Speight, +1-919-745-2745
Media: Lori Dorer, +1-513-345-1685

###

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: INC RESEARCH, LLC via Globenewswire


Topic: Press release summary
Source: INC Research, LLC


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



INC Research, LLC
Oct 7, 2014 07:10 HKT/SGT
INC Research Files Registration Statement for Initial Public Offering
Oct 3, 2014 10:30 HKT/SGT
INC Research Demonstrates Continued Dedication to Site Relationships at 2014 SCRS Site Solutions Summit
Oct 2, 2014 07:20 HKT/SGT
INC Research Further Reinforces Commitment to Clinical Research Sites and Patients through Creation of New Leadership Role
Aug 6, 2014 03:30 HKT/SGT
INC Research's Tara Fitzgerald and Judy Swilley Named to Annual PharmaVOICE 100
July 30, 2014 21:45 HKT/SGT
INC Research Appoints Jan Schreur Senior Vice President, Human Resources
July 17, 2014 07:10 HKT/SGT
INC Research Drives Deeper Site Connections Through Strengthened Study Start-up Effort
July 16, 2014 09:55 HKT/SGT
INC Research, LLC Second Quarter 2014 Results of Operations Release Date and Conference Call
June 12, 2014 07:55 HKT/SGT
INC Research Strengthens Connections with Drug Development Community at DIA 2014 Annual Meeting
May 29, 2014 07:55 HKT/SGT
INC Research Debuts New Interactive Website
May 28, 2014 06:35 HKT/SGT
INC Research Announces Partnership with Society for Clinical Research Sites
More news >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: